iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies
iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies division and drop the iMcKesson name. The company attributes the sudden restructuring to changes in market conditions. iMcKesson CEO David Mahoney, who was also co-CEO of McKesson/HBOC, plans to leave the company. John Hammergren, chair of the board, is now president and CEO of McKesson/HBOC. iMcKesson lost $124 million in the first nine months of the current fiscal year, although $95 million of that was attributed to write-offs on investments such as WebMD.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.